18 September 2023

GSK Stockmann recognized by IFLR1000

IFLR1000 has published the 2023 rankings based on its annual research and recognizes GSK Stockmann as “recommended firm” with practice and individual mentions in their new edition.

The following practice categories are ranked by IFLR1000:

  • Banking
  • Financial services regulatory
  • M&A
  • Investment funds
  • Restructuring and insolvency
  • Capital markets

The following lawyers are ranked by IFLR1000:

  • Manuel Fernandez:  Notable practitioner
  • Andreas Heinzmann: Highly regarded
  • Philipp Mössner: Rising star
  • Mathilde Ostertag: Notable practitioner
  • Marcus Peter: Highly regarded

The rankings underline the strength and ongoing development of GSK Stockmann’s practices in Luxembourg.

The full results are available at IFLR1000.com

IFLR1000 is a leading international legal market research product and undertakes qualitative research into law firms and lawyers to inform the publication of annual rankings, ratings and awards, and editorial content. The company has been producing legal market intelligence since 1990 and remains the only international legal market research brand focused on ranking law firms and lawyers on the basis of financial and corporate transactional work. Currently IFLR1000 ranks close to 5000 law firms and more than 21,000 lawyers across 12 practice areas and 250 jurisdictions – national and regional – globally.


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
© GSK Stockmann 2024